Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Blast Crisis × Calcium Dobesilate × Clear all

Phase

Phase 2 3 Phase NA 2 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 50 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Recurrence 9 Burkitt Lymphoma 7 Neoplasms, Plasma Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Immunoglobulin Light-chain Amyloidosis 5 Hodgkin Disease 4 Lymphoma, T-Cell 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Oligodendroglioma 2 Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma 2 Lymphoma, T-Cell, Cutaneous 2 Leukemia, Myeloid, Acute 2 Leukemia, Hairy Cell 2 Leukemia, Biphenotypic, Acute 2 Hematologic Neoplasms 2 Glioblastoma 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Astrocytoma 2 Amyloidosis 2 Waldenstrom Macroglobulinemia 1 Vascular Diseases 1 Uveal Melanoma 1

Interventions

Cytarabine 11 Cyclophosphamide 10 Filgrastim 9 Etoposide 8 fludarabine phosphate 6 Vorinostat 6 Tacrolimus 6 Peripheral Blood Stem Cell Transplantation 6 Imatinib Mesylate 6 Dasatinib 6 Carboplatin 5 tipifarnib 4 sargramostim 4 Topotecan 4 Sirolimus 4 Bortezomib 4 tanespimycin 3 fludarabine 3 alvocidib 3 Whole-Body Irradiation 3 Sorafenib 3 Flow Cytometry 3 Doxorubicin 3 Decitabine 3 Busulfan 3 Antilymphocyte Serum 3 3-aminopyridine-2-carboxaldehyde thiosemicarbazone 3 laromustine 2 entinostat 2 bryostatin 1 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204164 2016-05-06

TG02-101

Tragara Pharmaceuticals, Inc.

Phase 1 Completed

Blast Crisis, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡